Cipla Limited
CIPLA
주식 순위
#1811
Cipla Limited, along with its associated entities, operates as a global... Cipla Limited, along with its associated entities, operates as a global pharmaceutical enterprise, specializing in the creation and distribution of a wide array of medicinal products. Its extensive portfolio includes both active pharmaceutical ingredients (APIs) and a diverse range of finished formulations, addressing numerous therapeutic areas such as cardiovascular diseases, metabolic disorders, HIV, respiratory conditions, urology, oncology, pediatric health, infectious diseases, critical care, hepatitis, women's health, ophthalmology, and neuropsychiatry. The company maintains a strong focus on respiratory treatments, offering various inhalers, nasal sprays, injectables, and biosimilars. Cipla has also forged significant partnerships, including a licensing arrangement with Merck & Co., Inc. for the manufacturing and commercialization of the investigational oral antiviral drug Molnupiravir, and a separate license agreement with Eli Lilly and Company for baricitinib, indicated for COVID-19. Furthermore, it collaborates with Dr. Reddy's Laboratories Ltd, Sun Pharmaceutical Industries Limited, Emcure Pharmaceuticals Limited, and Torrent Pharmaceuticals Limited for Molnupiravir's clinical trials. Established in 1935, Cipla's corporate headquarters are located in Mumbai, India.
주가
$14.61
마지막 동기화: 2026-10-19
시가총액
$11.81B
변동 (1일)
-0.11%
변동 (1년)
-21.65%
국가
IN
거래 Cipla Limited (CIPLA)
카테고리
Healthcare
Cipla Limited (CIPLA)의 주식 분할 이력
Cipla Limited 주식 (심볼: CIPLA)은 총 4회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Apr 24, 2006에 발생했습니다.
Oct 18, 1999 이전에 매수한 CIPLA 주식 1주는 현재 112.5주의 CIPLA 주식에 해당합니다.
가장 최근의 분할은 Apr 24, 2006에 발생했습니다.
Oct 18, 1999 이전에 매수한 CIPLA 주식 1주는 현재 112.5주의 CIPLA 주식에 해당합니다.
주식 분할 목록
| 연도 | 주식 분할 | 배수 | 누적 배수 |
|---|---|---|---|
| 2006-04-24 | 5:2 | x2.5 | x112.5 |
| 2004-05-11 | 5:1 | x5 | x45 |
| 1999-10-21 | 3:1 | x3 | x9 |
| 1999-10-18 | 3:1 | x3 | x3 |
유사 기업 또는 경쟁사의 주식 분할
| 회사 | 주식 분할 횟수 | 누적 배수 | 국가 |
|---|---|---|---|
| 0 | - |
DE
|
|
| 0 | - |
DE
|
|
| 0 | - |
JP
|
|
| 0 | - |
CH
|
|
| 5 | x119 |
IN
|
